TWI744213B - System for detecting intravenous injection abnormality - Google Patents

System for detecting intravenous injection abnormality Download PDF

Info

Publication number
TWI744213B
TWI744213B TW110117427A TW110117427A TWI744213B TW I744213 B TWI744213 B TW I744213B TW 110117427 A TW110117427 A TW 110117427A TW 110117427 A TW110117427 A TW 110117427A TW I744213 B TWI744213 B TW I744213B
Authority
TW
Taiwan
Prior art keywords
result data
detection result
abnormality
injection
detector
Prior art date
Application number
TW110117427A
Other languages
Chinese (zh)
Other versions
TW202243697A (en
Inventor
張玉梅
賴金輪
Original Assignee
亞東學校財團法人亞東科技大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 亞東學校財團法人亞東科技大學 filed Critical 亞東學校財團法人亞東科技大學
Priority to TW110117427A priority Critical patent/TWI744213B/en
Application granted granted Critical
Publication of TWI744213B publication Critical patent/TWI744213B/en
Publication of TW202243697A publication Critical patent/TW202243697A/en

Links

Images

Abstract

A system for detecting intravenous injection abnormality is provided. The system includes a fixing module, a state examining module, and a processing module. The fixing module is configured to be detachably fixed to a hand of a user, and an intravenous retention needle is configured to penetrate through the fixing module and insert to the hand of the user. The state examining module includes a first examiner and a second examiner, and the first examiner and the second examiner can respectively transmit a first examine result data and a second examine result data to the processing module. The processing module can determine whether the first examine result data and the second examine result data respectively correspond to an injection abnormality state and a skin abnormality state, so as to correspondingly emit an injection abnormality alarm or a skin abnormality alarm.

Description

靜脈注射異常檢測系統Intravenous injection abnormality detection system

本發明涉及一種異常檢測系統,特別是涉及一種靜脈注射異常檢測系統。The invention relates to an abnormality detection system, in particular to an intravenous injection abnormality detection system.

在執行靜脈注射作業的過程中,可能會因為各種原因而造成各種異常的發生。例如,血液自靜脈中逆流回到靜脈注射留置針的回血異常、注射液並未完整地注射進入患者的靜脈中、或是因為靜脈注射留置針的位置偏移或是注射液的滲漏而造成患者扎針處的皮膚隆起。In the process of performing intravenous injection operations, various abnormalities may occur due to various reasons. For example, blood flow back from the vein back to the intravenous indwelling needle is abnormal, the injection is not completely injected into the patient's vein, or it is caused by the deviation of the intravenous indwelling needle or the leakage of the injection The patient's skin swelled where the needle was pierced.

現有的靜脈注射異常檢測系統無法有效地對靜脈注射作業的過程中的各種異常自動且立即進行檢測、判斷及警示,因此,在執行靜脈注射作業一段時間後,各種異常狀態才被護理師或醫師所發現。也就是說,現有的靜脈注射異常檢測系統會有時間成本及人力成本浪費的問題。Existing intravenous injection abnormality detection systems cannot effectively detect, judge and warn various abnormalities in the process of intravenous injection operations automatically and immediately. Therefore, after performing intravenous injection operations for a period of time, various abnormal conditions can be detected by nurses or physicians. Found. In other words, the existing intravenous injection abnormality detection system has the problem of time cost and labor cost waste.

故,如何改善現有的靜脈注射異常檢測系統,以克服上述的缺陷,已成為該項事業所欲解決的重要課題之一。Therefore, how to improve the existing intravenous injection abnormality detection system to overcome the above-mentioned shortcomings has become one of the important issues to be solved by this business.

本發明所要解決的技術問題在於,針對現有技術的不足提供一種靜脈注射異常檢測系統,其能有效地對靜脈注射作業的過程中的各種異常進行自動且立即檢測、判斷及警示,以改善現有的靜脈注射異常檢測系統會造成時間成本及人力成本浪費的問題。The technical problem to be solved by the present invention is to provide an intravenous injection abnormality detection system which can effectively detect, judge and warn various abnormalities in the process of intravenous injection operation in order to improve the existing Intravenous injection abnormality detection system will cause time cost and labor cost waste.

為了解決上述的技術問題,本發明所採用的其中一技術方案是提供一種靜脈注射異常檢測系統,其包括:一固定模組,能用以可拆卸地固定設置於一使用者的一手部;其中,所述固定模組具有一開孔,所述開孔能供一靜脈注射留置針穿過而使得所述靜脈注射留置針能插設於所述使用者的所述手部;一狀態檢測模組,鄰近所述固定模組設置,並且包含有一第一檢測器及一第二檢測器;其中,所述第一檢測器及所述第二檢測器能分別將所述第一檢測結果資料及所述第二檢測結果資料傳輸至一處理模組;以及所述處理模組,包含有:一異常判斷單元,能判斷所述第一檢測結果資料及所述第二檢測結果資料是否分別對應為一注射異常狀態及一皮膚異常狀態;其中,所述注射異常狀態定義為關於一注射液經所述靜脈注射留置針而被注射的異常狀態,並且所述皮膚異常狀態定義為關於所述靜脈注射留置針插設於所述使用者的所述手部且經注射所述注射液後的異常狀態;及一警示單元,能在所述異常判斷單元判斷所述第一檢測結果資料對應為所述注射異常狀態或所述第二檢測結果資料對應為所述皮膚異常狀態後,對應發出一注射異常警示或一皮膚異常警示。In order to solve the above technical problems, one of the technical solutions adopted by the present invention is to provide an intravenous injection abnormality detection system, which includes: a fixing module that can be detachably fixed on a hand of a user; wherein , The fixing module has an opening, and the opening can allow an intravenous injection indwelling needle to pass through so that the intravenous injection indwelling needle can be inserted into the hand of the user; a state detection module Set adjacent to the fixed module, and includes a first detector and a second detector; wherein, the first detector and the second detector can separate the first detection result data and The second detection result data is transmitted to a processing module; and the processing module includes: an abnormality judgment unit capable of judging whether the first detection result data and the second detection result data respectively correspond to An injection abnormal state and a skin abnormal state; wherein the injection abnormal state is defined as an abnormal state in which an injection solution is injected through the intravenous indwelling needle, and the skin abnormal state is defined as in relation to the intravenous injection The indwelling needle is inserted in the hand of the user and the abnormal state after the injection is injected; and a warning unit, which can determine that the first detection result data corresponds to the After the injection abnormal state or the second detection result data corresponds to the skin abnormal state, an injection abnormality warning or a skin abnormality warning is correspondingly issued.

本發明的其中一有益效果在於,本發明所提供的靜脈注射異常檢測系統,其能通過“所述第一檢測器及所述第二檢測器能分別將所述第一檢測結果資料及所述第二檢測結果資料傳輸至所述處理模組”、“所述異常判斷單元能判斷所述第一檢測結果資料及所述第二檢測結果資料是否分別對應為所述注射異常狀態及所述皮膚異常狀態”以及“所述警示單元能在所述異常判斷單元判斷所述第一檢測結果資料對應為所述注射異常狀態或所述第二檢測結果資料對應為所述皮膚異常狀態後,對應發出所述注射異常警示或所述皮膚異常警示”的技術方案,以有效地對靜脈注射作業的過程中的各種異常進行自動且立即檢測、判斷及警示。One of the beneficial effects of the present invention is that the intravenous injection abnormality detection system provided by the present invention can separate the first detection result data and the The second detection result data is transmitted to the processing module", "the abnormality determination unit can determine whether the first detection result data and the second detection result data correspond to the injection abnormal state and the skin, respectively "Abnormal state" and "the warning unit can issue correspondingly after the abnormality determination unit determines that the first detection result data corresponds to the injection abnormal state or the second detection result data corresponds to the skin abnormal state The "injection abnormality warning or the skin abnormality warning" technical solution is to effectively automatically and immediately detect, judge and warn various abnormalities in the process of intravenous injection operations.

為使能更進一步瞭解本發明的特徵及技術內容,請參閱以下有關本發明的詳細說明與圖式,然而所提供的圖式僅用於提供參考與說明,並非用來對本發明加以限制。In order to further understand the features and technical content of the present invention, please refer to the following detailed description and drawings about the present invention. However, the provided drawings are only for reference and description, and are not used to limit the present invention.

以下是通過特定的具體實施例來說明本發明所公開有關“靜脈注射異常檢測系統”的實施方式,本領域技術人員可由本說明書所公開的內容瞭解本發明的優點與效果。本發明可通過其他不同的具體實施例加以施行或應用,本說明書中的各項細節也可基於不同觀點與應用,在不悖離本發明的構思下進行各種修改與變更。另外,本發明的附圖僅為簡單示意說明,並非依實際尺寸的描繪,事先聲明。以下的實施方式將進一步詳細說明本發明的相關技術內容,但所公開的內容並非用以限制本發明的保護範圍。The following is a specific embodiment to illustrate the implementation of the "intravenous injection abnormality detection system" disclosed in the present invention. Those skilled in the art can understand the advantages and effects of the present invention from the content disclosed in this specification. The present invention can be implemented or applied through other different specific embodiments, and various details in this specification can also be based on different viewpoints and applications, and various modifications and changes can be made without departing from the concept of the present invention. In addition, the drawings of the present invention are merely schematic illustrations, and are not drawn according to actual dimensions, and are stated in advance. The following embodiments will further describe the related technical content of the present invention in detail, but the disclosed content is not intended to limit the protection scope of the present invention.

應當可以理解的是,雖然本文中可能會使用到“第一”、“第二”、“第三”等術語來描述各種元件或者信號,但這些元件或者信號不應受這些術語的限制。這些術語主要是用以區分一元件與另一元件,或者一信號與另一信號。另外,本文中所使用的術語“或”,應視實際情況可能包括相關聯的列出項目中的任一個或者多個的組合。It should be understood that although terms such as "first", "second", and "third" may be used herein to describe various elements or signals, these elements or signals should not be limited by these terms. These terms are mainly used to distinguish one element from another, or one signal from another signal. In addition, the term "or" used in this document may include any one or a combination of more of the associated listed items depending on the actual situation.

[第一實施例][First Embodiment]

參閱圖1至圖3所示,圖1為本發明第一實施例的靜脈注射異常檢測系統搭配於一靜脈注射留置針的示意圖,圖2為本發明第一實施例的靜脈注射異常檢測系統的方塊示意圖,並且圖3為本發明第一實施例的靜脈注射異常檢測系統的第一檢測器設置於靜脈注射留置針的示意圖。本發明第一實施例提供一種靜脈注射異常檢測系統100。在對一使用者執行一靜脈注射作業時,所述靜脈注射異常檢測系統100能自動檢測並判斷是否有異常狀態發生,並且在異常狀態發生時發出相關的警示。所述靜脈注射異常檢測系統100包含有一固定模組1、一狀態檢測模組2及一處理模組3。Referring to Figures 1 to 3, Figure 1 is a schematic diagram of the intravenous injection abnormality detection system according to the first embodiment of the present invention combined with an intravenous indwelling needle, and Figure 2 is a schematic diagram of the intravenous injection abnormality detection system according to the first embodiment of the present invention. It is a block diagram, and FIG. 3 is a schematic diagram of the first detector of the intravenous injection abnormality detection system according to the first embodiment of the present invention disposed on the intravenous injection indwelling needle. The first embodiment of the present invention provides an intravenous injection abnormality detection system 100. When performing an intravenous injection operation for a user, the intravenous injection abnormality detection system 100 can automatically detect and determine whether an abnormal state occurs, and issue a related warning when the abnormal state occurs. The intravenous injection abnormality detection system 100 includes a fixed module 1, a state detection module 2 and a processing module 3.

所述固定模組1能用以可拆卸地固定設置於所述使用者的一手部。所述固定模組1具有一開孔1a,所述開孔能供一靜脈注射留置針N穿過而使得所述靜脈注射留置針N能插設於所述使用者的所述手部。在將所述靜脈注射留置針N穿過所述開孔1a而插設於所述使用者的所述手部,相關人員可以通過所述靜脈注射留置針N而將一個或多個注射液注入所述使用者的靜脈中(也就是所述靜脈注射作業)。The fixing module 1 can be used to be detachably fixed on a hand of the user. The fixing module 1 has an opening 1a through which an intravenous injection indwelling needle N can pass so that the intravenous injection indwelling needle N can be inserted into the hand of the user. After inserting the intravenous indwelling needle N through the opening 1a and inserting it into the user’s hand, the relevant personnel can inject one or more injections through the intravenous indwelling needle N In the vein of the user (that is, the intravenous injection operation).

通過以所述固定模組1將所述靜脈注射異常檢測系統100設置於所述使用者的手部的設計,本發明的所述靜脈注射異常檢測系統100能特別適合用於嬰幼兒,以避免嬰幼兒因為不受控制地揮動手部而造成在執行所述靜脈注射作業時各種異常的發生。By using the fixed module 1 to install the intravenous injection abnormality detection system 100 on the user’s hand, the intravenous injection abnormality detection system 100 of the present invention can be particularly suitable for infants and young children to avoid Infants and young children wave their hands uncontrollably, causing various abnormalities when performing the intravenous injection operation.

所述固定模組1還可以具有至少一個穿孔1b以供所述使用者的手指穿設,但所述固定模組1的結構可以依據需求變化,本發明於此不加以限制。另外,於本實施例中,所述固定模組1是以設置於所述使用者的手掌部位為例,但本發明不受限於此。舉例來說,所述固定模組1也可以是設置於所述使用者的前臂部位。The fixing module 1 may also have at least one perforation 1b for the user's fingers to pass through, but the structure of the fixing module 1 can be changed according to requirements, and the present invention is not limited herein. In addition, in this embodiment, the fixing module 1 is set on the palm of the user as an example, but the present invention is not limited to this. For example, the fixed module 1 may also be installed on the forearm of the user.

所述狀態檢測模組2鄰近所述固定模組1設置,並且所述狀態檢測模組2能對執行所述靜脈注射作業中的各種異常狀態進行檢測。具體來說,所述狀態檢測模組2包含有一第一檢測器21及一第二檢測器22,並且所述第一檢測器21及所述第二檢測器22能分別將所述第一檢測器21進行檢測而得到的一第一檢測結果資料及所述第二檢測器22進行檢測而得到的一第二檢測結果資料傳輸至所述處理模組3。值得一提的是,所述第一檢測器21及所述第二檢測器22可以是通過有線方式或無線方式分別將所述第一檢測結果資料及所述第二檢測結果資料傳輸至所述處理模組3,但本發明不受限於此。The state detection module 2 is arranged adjacent to the fixed module 1, and the state detection module 2 can detect various abnormal states during the execution of the intravenous injection operation. Specifically, the state detection module 2 includes a first detector 21 and a second detector 22, and the first detector 21 and the second detector 22 can respectively detect the first detector 21 and the second detector 22. A first detection result data obtained by the detection by the device 21 and a second detection result data obtained by the detection by the second detector 22 are transmitted to the processing module 3. It is worth mentioning that the first detector 21 and the second detector 22 may respectively transmit the first detection result data and the second detection result data to the Processing module 3, but the present invention is not limited to this.

所述處理模組3包含有一異常判斷單元31及一警示單元32。所述處理模組3可以例如是各式處理器、電腦、或伺服器,但本發明不受限於此。所述異常判斷單元31能判斷所述第一檢測結果資料及所述第二檢測結果資料是否分別對應為一注射異常狀態及一皮膚異常狀態。具體來說,所述注射異常狀態定義為關於一注射液經所述靜脈注射留置針而被注射的異常狀態,並且所述皮膚異常狀態定義為關於所述靜脈注射留置針插設於所述使用者的所述手部且經注射所述注射液後的異常狀態。此外,於實際應用時,所述異常判斷單元31也可以判斷所述第一檢測結果資料或所述第二檢測結果資料為一無異常狀態。The processing module 3 includes an abnormality judgment unit 31 and a warning unit 32. The processing module 3 may be, for example, various types of processors, computers, or servers, but the present invention is not limited thereto. The abnormality determination unit 31 can determine whether the first detection result data and the second detection result data correspond to an injection abnormal state and a skin abnormal state, respectively. Specifically, the abnormal state of injection is defined as an abnormal state in which an injection solution is injected through the intravenous indwelling needle, and the abnormal state of the skin is defined as an abnormal state in which the intravenous indwelling needle is inserted in the use The abnormal state of the hands of the person after the injection of the injection. In addition, in practical applications, the abnormality determination unit 31 may also determine that the first detection result data or the second detection result data is in a non-abnormal state.

所述警示單元32能在所述異常判斷單元31判斷所述第一檢測結果資料對應為所述注射異常狀態或所述第二檢測結果資料對應為所述皮膚異常狀態後,對應發出一注射異常警示或一皮膚異常警示。當然,於實際應用時,所述警示單元32能在所述異常判斷單元31判斷所述第一檢測結果資料對應為所述注射異常狀態且所述第二檢測結果資料對應為所述皮膚異常狀態後,同時發出所述注射異常警示及所述皮膚異常警示。所述警示單元32可以例如是一顯示螢幕、發聲器或震動器,分別通過螢幕顯示方式、發聲方式、或震動方式來警示相關人員所述注射異常狀態、所述皮膚異常狀態或以上兩者同時發生。The warning unit 32 can correspondingly issue an injection abnormality after the abnormality determining unit 31 determines that the first detection result data corresponds to the injection abnormal state or the second detection result data corresponds to the skin abnormal state. A warning or a skin abnormality warning. Of course, in actual applications, the warning unit 32 can determine in the abnormality determining unit 31 that the first detection result data corresponds to the injection abnormal state and the second detection result data corresponds to the skin abnormal state After that, the injection abnormality warning and the skin abnormality warning are issued at the same time. The warning unit 32 may be, for example, a display screen, a sounder or a vibrator, which warns the relevant personnel of the abnormal state of injection, the abnormal state of the skin, or both simultaneously through a screen display mode, a sound mode, or a vibration mode. happen.

所述第一檢測器21可以是可拆卸地固定於所述靜脈注射留置針N。進一步來說,於本實施例中,所述第一檢測器21可以包含有位於所述靜脈注射留置針N的一側的一光發射單元211及位於所述靜脈注射留置針N的另一側的一光接收單元212,所述光發射單元211能發射具有一預定波長的一光束,並且所述光接收單元212能接收所述光束且能傳輸包含於所述第一檢測結果資料的一波長檢測結果資料傳輸至所述處理模組3。具體來說,所述預定波長為介於800奈米至900奈米之間。The first detector 21 may be detachably fixed to the intravenous indwelling needle N. Furthermore, in this embodiment, the first detector 21 may include a light emitting unit 211 located on one side of the intravenous indwelling needle N and a light emitting unit 211 located on the other side of the intravenous indwelling needle N A light receiving unit 212 of the light emitting unit 211 can emit a light beam having a predetermined wavelength, and the light receiving unit 212 can receive the light beam and can transmit a wavelength included in the first detection result data The detection result data is transmitted to the processing module 3. Specifically, the predetermined wavelength is between 800 nanometers and 900 nanometers.

在所述處理模組3接收所述波長檢測結果資料後,所述異常判斷單元31藉由所述波長檢測結果資料判斷所述光接收單元212所接收的所述光束是否於一特定波長發生衰減而判斷一回血異常是否發生,而當所述回血異常發生時,所述注射異常狀態定義為包含一回血異常狀態。After the processing module 3 receives the wavelength detection result data, the abnormality determination unit 31 uses the wavelength detection result data to determine whether the light beam received by the light receiving unit 212 is attenuated at a specific wavelength It is determined whether a blood return abnormality occurs, and when the blood return abnormality occurs, the injection abnormal state is defined as including a blood return abnormal state.

具體來說,所述特定波長為介於820奈米至880奈米之間,較佳地,所述特定波長約為850奈米。需要說明的是,由於血液會大量地吸收波長約為850奈米的光,因此當血液自靜脈中逆流回到所述靜脈注射留置針N(也就是所述回血異常)中時,位於所述靜脈注射留置針N的一側的所述光發射單元211所發出的光束中,波長約為850奈米的光大量地被吸收,而使得位於所述靜脈注射留置針N的另一側的所述光接收單元212接收相對較少波長約為850奈米的光,據此以判斷所述回血異常的發生。Specifically, the specific wavelength is between 820 nanometers and 880 nanometers, and preferably, the specific wavelength is about 850 nanometers. It should be noted that because blood absorbs a large amount of light with a wavelength of about 850 nanometers, when blood flows back from the vein back to the intravenous indwelling needle N (that is, the abnormal blood return), it is located in the In the light beam emitted by the light emitting unit 211 on one side of the intravenous indwelling needle N, a large amount of light with a wavelength of about 850 nanometers is absorbed, so that the light beam located on the other side of the intravenous indwelling needle N The light receiving unit 212 receives a relatively small amount of light with a wavelength of about 850 nanometers, so as to determine the occurrence of the abnormal blood return.

所述第二檢測器22可以是覆蓋於所述靜脈注射留置針N的一端及所述手部的鄰近於所述靜脈注射留置針N的一端的皮膚部位。於本實施例中,所述第二檢測器22為一光強度檢測器,所述光強度檢測器能發射至少一光束至所述手部的所述皮膚部位、在所述皮膚部位反射所述光束後接收所述光束並檢測所述光束的一光強度變化量、並且將包含於所述第二檢測結果資料的一光強度變化量檢測結果資料傳輸至所述處理模組3。進一步來說,所述光強度檢測器可以是發射呈矩陣排列(如:四乘四矩陣或九乘九矩陣等)的多個光束,以提高檢測精度,但本發明不對所述光強度檢測器所發出的所述光束的數量及排列方式加以限制。The second detector 22 may cover one end of the intravenous injection indwelling needle N and a skin part of the hand adjacent to one end of the intravenous injection indwelling needle N. In this embodiment, the second detector 22 is a light intensity detector that can emit at least one light beam to the skin part of the hand, and reflect the light intensity at the skin part. After the light beam is received, the light beam is detected and a light intensity change amount of the light beam is detected, and a light intensity change amount detection result data included in the second detection result data is transmitted to the processing module 3. Further, the light intensity detector may emit multiple light beams arranged in a matrix (such as a four-by-four matrix or a nine-by-nine matrix, etc.) to improve detection accuracy, but the present invention does not apply to the light intensity detector. The number and arrangement of the emitted light beams are limited.

在所述處理模組3接收所述光強度變化量檢測結果資料後,所述異常判斷單元31藉由所述光強度變化量檢測結果資料判斷所述光強度變化量是否高於一預定光強度變化量而判斷一皮膚隆起異常是否發生,而當所述皮膚隆起異常發生時,所述皮膚異常狀態定義為包含一皮膚隆起異常狀態。After the processing module 3 receives the light intensity variation detection result data, the abnormality determination unit 31 determines whether the light intensity variation is higher than a predetermined light intensity based on the light intensity variation detection result data The amount of change is used to determine whether a skin bulge abnormality occurs, and when the skin bulge abnormality occurs, the skin abnormal state is defined as including a skin bulge abnormal state.

[第二實施例][Second Embodiment]

請參閱圖4及5所示,圖4為本發明第二實施例的靜脈注射異常檢測系統的方塊示意圖,並且圖5為本發明第二實施例的靜脈注射異常檢測系統的第一檢測器設置於靜脈注射留置針的示意圖。本實施例類似於上述第一實施例,所以兩個實施例的相同處則不再加以贅述,而兩個實施例的差異處大致說明如下。Please refer to FIGS. 4 and 5. FIG. 4 is a block diagram of the intravenous injection abnormality detection system according to the second embodiment of the present invention, and FIG. 5 is the first detector setting of the intravenous injection abnormality detection system according to the second embodiment of the present invention Schematic diagram of the indwelling needle for intravenous injection. This embodiment is similar to the above-mentioned first embodiment, so the similarities between the two embodiments will not be described again, and the differences between the two embodiments are roughly explained as follows.

所述第一檢測器21還可以包含有一流量檢測單元213,所述流量檢測單元213能用以檢測流通過所述靜脈注射留置針N的所述注射液的一流量並且將包含於所述第一檢測結果資料的一流量檢測結果資料傳輸至所述處理模組3。所述流量檢測單元213可以例如是一外夾式超音波流量計,其能用以夾持於所述靜脈注射留置針N的外周圍並且利用超音波方式檢測所述靜脈注射留置針內的流量。需要說明的是,只要所述流量檢測單元213能用以檢測所述靜脈注射留置針N內的流量,本發明不對所述流量檢測單元213的外形、設置方式及流量檢測方法加以限制。The first detector 21 may also include a flow detection unit 213, which can be used to detect a flow of the injection solution flowing through the intravenous indwelling needle N and will be included in the first A flow detection result data of a detection result data is transmitted to the processing module 3. The flow detection unit 213 may be, for example, an external clamp-type ultrasonic flowmeter, which can be used to clamp the outer periphery of the intravenous indwelling needle N and detect the flow rate in the intravenous indwelling needle by means of ultrasonic waves. . It should be noted that, as long as the flow detection unit 213 can be used to detect the flow in the intravenous indwelling needle N, the present invention does not limit the shape, arrangement and flow detection method of the flow detection unit 213.

在所述處理模組3接收所述流量檢測結果資料後,所述異常判斷單元31藉由所述流量檢測結果資料判斷所述注射液的所述流量是否低於一預定流量而判斷一流量過低異常是否發生,而當所述流量過低異常發生時,所述注射異常狀態定義為包含一流量過低異常狀態。After the processing module 3 receives the flow rate detection result data, the abnormality determination unit 31 determines whether the flow rate of the injection solution is lower than a predetermined flow rate by using the flow rate detection result data to determine that a flow rate is too high. Whether a low abnormality occurs, and when the abnormally low flow occurs, the abnormal injection state is defined as including an abnormal low flow abnormal state.

需要說明的是,於本實施例中,所述第一檢測器21包含有所述光發射單元211及所述光接收單元212(如第一實施例)與所述流量檢測單元213,並且所述回血異常及所述流量過低異常同時發生時,所述注射異常狀態則包含所述回血異常狀態及所述流量過低異常狀態。當然,於本發明未繪示的其他實施例中,所述第一檢測器21也可以包含有不同於所述光發射單元211、所述光接收單元212及所述流量檢測單元213的其他異常檢測單元,並且所述注射異常狀態也可以是包含有其他異常狀態。It should be noted that in this embodiment, the first detector 21 includes the light emitting unit 211 and the light receiving unit 212 (as in the first embodiment) and the flow detection unit 213, and When the abnormal blood return and the abnormal low flow rate occur at the same time, the abnormal state of injection includes the abnormal state of blood return and the abnormal state of low flow rate. Of course, in other embodiments not shown in the present invention, the first detector 21 may also include other abnormalities different from the light emitting unit 211, the light receiving unit 212, and the flow detection unit 213. The detection unit, and the injection abnormal state may also include other abnormal states.

[第三實施例][Third Embodiment]

本實施例類似於上述第一實施例,所以兩個實施例的相同處則不再加以贅述,而兩個實施例的差異處大致說明如下。This embodiment is similar to the above-mentioned first embodiment, so the similarities between the two embodiments will not be described again, and the differences between the two embodiments are roughly explained as follows.

所述第二檢測器22為一阻抗檢測器,所述阻抗檢測器能檢測所述手部的所述皮膚部位的一阻抗值變化量並且將包含於所述第二檢測結果資料的一阻抗值變化量檢測結果資料傳輸至所述處理模組3。The second detector 22 is an impedance detector that can detect a change in impedance value of the skin part of the hand and will include an impedance value in the second detection result data The change detection result data is transmitted to the processing module 3.

在所述處理模組3接收所述阻抗值變化量檢測結果資料後,所述異常判斷單元31藉由所述阻抗值變化量檢測結果資料判斷所述阻抗值變化量是否高於一預定阻抗值變化量而判斷一皮膚隆起異常是否發生,而當所述皮膚隆起異常發生時,所述皮膚異常狀態定義為包含所述皮膚隆起異常狀態。After the processing module 3 receives the impedance value change amount detection result data, the abnormality determination unit 31 determines whether the impedance value change amount is higher than a predetermined impedance value based on the impedance value change amount detection result data The amount of change is used to determine whether a skin bulge abnormality occurs, and when the skin bulge abnormality occurs, the skin abnormal state is defined as including the skin bulge abnormal state.

需要說明的是,相關人員可以依據實際應用情形,選擇以所述阻抗檢測器(如本實施例)或所述光強度檢測器(如上述第一實施例)作為所述第二檢測器22。然而,只要所述第二檢測器22能用以檢測所述皮膚異常狀態,所述第二檢測器22也可以利用其他方式進行檢測,本發明於此不加以限制。當然,於本發明未繪示的其他實施例中,所述第二檢測器22也可以是包含其他異常檢測器,並且所述皮膚異常狀態則包含有其他異常狀態,但本發明於此不加以限制。It should be noted that the relevant personnel can choose the impedance detector (such as this embodiment) or the light intensity detector (such as the above-mentioned first embodiment) as the second detector 22 according to the actual application situation. However, as long as the second detector 22 can be used to detect the abnormal state of the skin, the second detector 22 can also be used for detection in other ways, and the present invention is not limited herein. Of course, in other embodiments not shown in the present invention, the second detector 22 may also include other abnormality detectors, and the skin abnormal state includes other abnormal states, but the present invention does not add them here. limit.

[本發明實施例的有益效果][Beneficial Effects of Embodiments of the Invention]

本發明的其中一有益效果在於,本發明所提供的靜脈注射異常檢測系統,其能通過“所述第一檢測器及所述第二檢測器能分別將所述第一檢測結果資料及所述第二檢測結果資料傳輸至所述處理模組”、“所述異常判斷單元能判斷所述第一檢測結果資料及所述第二檢測結果資料是否分別對應為所述注射異常狀態及所述皮膚異常狀態”以及“所述警示單元能在所述異常判斷單元判斷所述第一檢測結果資料對應為所述注射異常狀態或所述第二檢測結果資料對應為所述皮膚異常狀態後,對應發出所述注射異常警示或所述皮膚異常警示”的技術方案,以有效地對靜脈注射作業的過程中的各種異常進行自動且立即檢測、判斷及警示。One of the beneficial effects of the present invention is that the intravenous injection abnormality detection system provided by the present invention can separate the first detection result data and the The second detection result data is transmitted to the processing module", "the abnormality determination unit can determine whether the first detection result data and the second detection result data correspond to the injection abnormal state and the skin, respectively "Abnormal state" and "the warning unit can issue correspondingly after the abnormality determination unit determines that the first detection result data corresponds to the injection abnormal state or the second detection result data corresponds to the skin abnormal state The "injection abnormality warning or the skin abnormality warning" technical solution is to effectively automatically and immediately detect, judge and warn various abnormalities in the process of intravenous injection operations.

以上所公開的內容僅為本發明的優選可行實施例,並非因此侷限本發明的申請專利範圍,所以凡是運用本發明說明書及圖式內容所做的等效技術變化,均包含於本發明的申請專利範圍內。The content disclosed above is only the preferred and feasible embodiments of the present invention, and does not limit the scope of the patent application of the present invention. Therefore, all equivalent technical changes made using the description and schematic content of the present invention are included in the application of the present invention. Within the scope of the patent.

100:靜脈注射異常檢測系統100: Intravenous injection abnormality detection system

1:固定模組1: Fixed module

1a:開孔1a: opening

1b:穿孔1b: Piercing

2:狀態檢測模組2: Status detection module

21:第一檢測器21: The first detector

211:光發射單元211: light emitting unit

212:光接收單元212: light receiving unit

213:流量檢測單元213: Flow detection unit

22:第二檢測器22: second detector

3:處理模組3: Processing module

31:異常判斷單元31: Abnormal Judgment Unit

32:警示單元32: warning unit

N:靜脈注射留置針N: Indwelling needle for intravenous injection

圖1為本發明第一實施例的靜脈注射異常檢測系統搭配於一靜脈注射留置針的示意圖。FIG. 1 is a schematic diagram of the intravenous injection abnormality detection system according to the first embodiment of the present invention combined with an intravenous indwelling needle.

圖2為本發明第一實施例的靜脈注射異常檢測系統的方塊示意圖。2 is a block diagram of the intravenous injection abnormality detection system according to the first embodiment of the present invention.

圖3為本發明第一實施例的靜脈注射異常檢測系統的第一檢測器設置於靜脈注射留置針的示意圖。FIG. 3 is a schematic diagram of the first detector of the intravenous injection abnormality detection system according to the first embodiment of the present invention being set on the intravenous injection indwelling needle.

圖4為本發明第二實施例的靜脈注射異常檢測系統的方塊示意圖。Fig. 4 is a block diagram of the intravenous injection abnormality detection system according to the second embodiment of the present invention.

圖5為本發明第二實施例的靜脈注射異常檢測系統的第一檢測器設置於靜脈注射留置針的示意圖。FIG. 5 is a schematic diagram of the first detector of the intravenous injection abnormality detection system according to the second embodiment of the present invention being set on the intravenous injection indwelling needle.

100:靜脈注射異常檢測系統 100: Intravenous injection abnormality detection system

1:固定模組 1: Fixed module

1a:開孔 1a: opening

1b:穿孔 1b: Piercing

2:狀態檢測模組 2: Status detection module

21:第一檢測器 21: The first detector

211:光發射單元 211: light emitting unit

212:光接收單元 212: light receiving unit

22:第二檢測器 22: second detector

N:靜脈注射留置針 N: Indwelling needle for intravenous injection

Claims (10)

一種靜脈注射異常檢測系統,其包括:一固定模組,能用以可拆卸地固定設置於一使用者的一手部;其中,所述固定模組具有一開孔,所述開孔能供一靜脈注射留置針穿過而使得所述靜脈注射留置針能插設於所述使用者的所述手部;一狀態檢測模組,鄰近所述固定模組設置,並且包含有一第一檢測器及一第二檢測器;其中,所述第一檢測器及所述第二檢測器能分別將一第一檢測結果資料及一第二檢測結果資料傳輸至一處理模組;以及所述處理模組,包含有:一異常判斷單元,能判斷所述第一檢測結果資料及所述第二檢測結果資料是否分別對應為一注射異常狀態及一皮膚異常狀態;其中,所述注射異常狀態定義為關於一注射液經所述靜脈注射留置針而被注射的異常狀態,並且所述皮膚異常狀態定義為關於所述靜脈注射留置針插設於所述使用者的所述手部且經注射所述注射液後的異常狀態;及一警示單元,能在所述異常判斷單元判斷所述第一檢測結果資料對應為所述注射異常狀態或所述第二檢測結果資料對應為所述皮膚異常狀態後,對應發出一注射異常警示或一皮膚異常警示。 An intravenous injection abnormality detection system, comprising: a fixing module that can be used to detachably fix a hand of a user; wherein the fixing module has an opening, and the opening can provide a The intravenous indwelling needle passes through so that the intravenous indwelling needle can be inserted into the hand of the user; a state detection module is arranged adjacent to the fixed module, and includes a first detector and A second detector; wherein the first detector and the second detector can respectively transmit a first detection result data and a second detection result data to a processing module; and the processing module , Including: an abnormality judgment unit capable of judging whether the first detection result data and the second detection result data correspond to an abnormal injection state and an abnormal skin state, respectively; wherein the abnormal injection state is defined as about An abnormal state in which an injection is injected through the intravenous indwelling needle, and the abnormal state of the skin is defined as an abnormal state in which the intravenous indwelling needle is inserted in the hand of the user and the injection is injected An abnormal state after the liquid; and a warning unit capable of determining that the first detection result data corresponds to the injection abnormal state or the second detection result data corresponds to the skin abnormal state after the abnormality determination unit determines, Correspondingly, a warning about injection abnormalities or a warning about skin abnormalities will be issued. 如請求項1所述的靜脈注射異常檢測系統,其中,所述第一檢測器能用以可拆卸地固定於所述靜脈注射留置針,所述第一檢測器包含有位於所述靜脈注射留置針的一側的一光發射單元及位於所述靜脈注射留置針的另一側的一光接收單元,所述光發射單元能發射具有一預定波長的一光束,並且所述 光接收單元能接收所述光束且能傳輸包含於所述第一檢測結果資料的一波長檢測結果資料傳輸至所述處理模組。 The intravenous injection abnormality detection system according to claim 1, wherein the first detector can be detachably fixed to the intravenous indwelling needle, and the first detector includes A light emitting unit on one side of the needle and a light receiving unit on the other side of the intravenous indwelling needle, the light emitting unit can emit a light beam with a predetermined wavelength, and the The light receiving unit can receive the light beam and can transmit a wavelength detection result data included in the first detection result data to the processing module. 如請求項2所述的靜脈注射異常檢測系統,其中,所述預定波長為介於800奈米至900奈米之間;其中,在所述處理模組接收所述波長檢測結果資料後,所述異常判斷單元藉由所述波長檢測結果資料判斷所述光接收單元所接收的所述光束是否於一特定波長發生衰減而判斷一回血異常是否發生,而當所述回血異常發生時,所述注射異常狀態定義為包含一回血異常狀態;其中,所述特定波長為介於820奈米至880奈米之間。 The intravenous injection abnormality detection system according to claim 2, wherein the predetermined wavelength is between 800 nanometers and 900 nanometers; wherein, after the processing module receives the wavelength detection result data, all The abnormality determining unit determines whether the light beam received by the light receiving unit is attenuated at a specific wavelength based on the wavelength detection result data to determine whether a blood return abnormality occurs, and when the blood return abnormality occurs, the An abnormal state of injection is defined as including an abnormal state of blood; where the specific wavelength is between 820 nanometers and 880 nanometers. 如請求項1所述的靜脈注射異常檢測系統,其中,所述第一檢測器包含有一流量檢測單元,所述流量檢測單元能用以檢測流通過所述靜脈注射留置針的所述注射液的一流量並且將包含於所述第一檢測結果資料的一流量檢測結果資料傳輸至所述處理模組。 The intravenous injection abnormality detection system according to claim 1, wherein the first detector includes a flow detection unit, and the flow detection unit can be used to detect the flow of the injection liquid through the intravenous indwelling needle. A flow rate and a flow rate detection result data included in the first detection result data are transmitted to the processing module. 如請求項4所述的靜脈注射異常檢測系統,其中,在所述處理模組接收所述流量檢測結果資料後,所述異常判斷單元藉由所述流量檢測結果資料判斷所述注射液的所述流量是否低於一預定流量而判斷一流量過低異常是否發生,而當所述流量過低異常發生時,所述注射異常狀態定義為包含一流量過低異常狀態。 The intravenous injection abnormality detection system according to claim 4, wherein, after the processing module receives the flow detection result data, the abnormality judgment unit judges the flow detection result data of the injection solution. Whether the flow rate is lower than a predetermined flow rate is used to determine whether a flow rate abnormality occurs, and when the flow rate abnormality occurs, the injection abnormal state is defined as including a flow rate abnormal state. 如請求項1所述的靜脈注射異常檢測系統,其中,所述第二檢測器覆蓋於所述靜脈注射留置針的一端及所述手部的鄰近於所述靜脈注射留置針的一端的皮膚部位。 The intravenous injection abnormality detection system according to claim 1, wherein the second detector covers one end of the intravenous injection indwelling needle and a skin part of the hand adjacent to one end of the intravenous injection indwelling needle . 如請求項6所述的靜脈注射異常檢測系統,其中,所述第二檢測器為一光強度檢測器,所述光強度檢測器能發射至少一光束至所述手部的所述皮膚部位、在所述皮膚部位反射所述 光束後接收所述光束並檢測所述光束的一光強度變化量、並且將包含於所述第二檢測結果資料的一光強度變化量檢測結果資料傳輸至所述處理模組。 The intravenous injection abnormality detection system according to claim 6, wherein the second detector is a light intensity detector, and the light intensity detector can emit at least one light beam to the skin part of the hand, Reflect the said on the skin site After the light beam is received, the light beam is detected and a light intensity change amount of the light beam is detected, and a light intensity change amount detection result data included in the second detection result data is transmitted to the processing module. 如請求項7所述的靜脈注射異常檢測系統,其中,在所述處理模組接收所述光強度變化量檢測結果資料後,所述異常判斷單元藉由所述光強度變化量檢測結果資料判斷所述光強度變化量是否高於一預定光強度變化量而判斷一皮膚隆起異常是否發生,而當所述皮膚隆起異常發生時,所述皮膚異常狀態定義為包含一皮膚隆起異常狀態。 The intravenous injection abnormality detection system according to claim 7, wherein, after the processing module receives the light intensity change detection result data, the abnormality determination unit judges based on the light intensity change detection result data Whether the light intensity change amount is higher than a predetermined light intensity change amount is used to determine whether a skin bulge abnormality occurs, and when the skin bulge abnormality occurs, the skin abnormal state is defined as including a skin bulge abnormal state. 如請求項6所述的靜脈注射異常檢測系統,其中,所述第二檢測器為一阻抗檢測器,所述阻抗檢測器能檢測所述手部的所述皮膚部位的一阻抗值變化量並且將包含於所述第二檢測結果資料的一阻抗值變化量檢測結果資料傳輸至所述處理模組。 The intravenous injection abnormality detection system according to claim 6, wherein the second detector is an impedance detector, and the impedance detector can detect an impedance value change amount of the skin part of the hand, and The detection result data of an impedance value change amount included in the second detection result data is transmitted to the processing module. 如請求項9所述的靜脈注射異常檢測系統,其中,在所述處理模組接收所述阻抗值變化量檢測結果資料後,所述異常判斷單元藉由所述阻抗值變化量檢測結果資料判斷所述阻抗值變化量是否高於一預定阻抗值變化量而判斷一皮膚隆起異常是否發生,而當所述皮膚隆起異常發生時,所述皮膚異常狀態定義為包含一皮膚隆起異常狀態。The intravenous injection abnormality detection system according to claim 9, wherein, after the processing module receives the impedance value change amount detection result data, the abnormality determination unit judges based on the impedance value change amount detection result data Whether the change of the impedance value is higher than a predetermined change of the impedance value is used to determine whether a skin bulge abnormality occurs, and when the skin bulge abnormality occurs, the skin abnormal state is defined as including a skin bulge abnormal state.
TW110117427A 2021-05-14 2021-05-14 System for detecting intravenous injection abnormality TWI744213B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW110117427A TWI744213B (en) 2021-05-14 2021-05-14 System for detecting intravenous injection abnormality

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW110117427A TWI744213B (en) 2021-05-14 2021-05-14 System for detecting intravenous injection abnormality

Publications (2)

Publication Number Publication Date
TWI744213B true TWI744213B (en) 2021-10-21
TW202243697A TW202243697A (en) 2022-11-16

Family

ID=80782808

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110117427A TWI744213B (en) 2021-05-14 2021-05-14 System for detecting intravenous injection abnormality

Country Status (1)

Country Link
TW (1) TWI744213B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017088153A1 (en) * 2015-11-26 2017-06-01 深圳市泽智知识产权有限公司 Leakage detection device for medical devices
CN209060203U (en) * 2018-09-11 2019-07-05 郑州大学 A kind of patients with intravenous transfusion induced exosmosis warning device
TWM598395U (en) * 2020-01-22 2020-07-11 國軍桃園總醫院 Bleeding sensing device

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017088153A1 (en) * 2015-11-26 2017-06-01 深圳市泽智知识产权有限公司 Leakage detection device for medical devices
CN209060203U (en) * 2018-09-11 2019-07-05 郑州大学 A kind of patients with intravenous transfusion induced exosmosis warning device
TWM598395U (en) * 2020-01-22 2020-07-11 國軍桃園總醫院 Bleeding sensing device

Also Published As

Publication number Publication date
TW202243697A (en) 2022-11-16

Similar Documents

Publication Publication Date Title
CN104837413B (en) Detect the device and method of removable cap on ultrasonic detector
US7087033B2 (en) Method and apparatus for leak detection in a fluid line
US9289550B1 (en) Apparatus and method for detecting fluid extravasation
BR112020011772A2 (en) sensor monitoring system for permanent catheter based treatments
US20110021922A1 (en) Monitoring the flow of fluid
Axley et al. Venous needle dislodgement in patients on hemodialysis
CN204683773U (en) Medical external hemorrhage alarm device
JP2007000621A (en) Mechanism sensing falling of needle
US8323194B2 (en) Detection of bubbles during hemodynamic monitoring when performing automated measurement of blood constituents
TWI744213B (en) System for detecting intravenous injection abnormality
AU2014270517B2 (en) Method and device for monitoring an extracorporeal blood circuit
CN105688303A (en) Portable blood purifying system bubble monitoring device and method
Zhou et al. Cuffing‐based photoacoustic flowmetry in humans in the optical diffusive regime
CN103055364A (en) Bubble monitoring device for portable blood purification system
AhlmEN et al. A new safety device for hemodialysis
CN206007719U (en) A kind of device for detecting transfusion device pipeline bubble size
US20070112329A1 (en) Infiltration detection system
Tonelli et al. Access flow in arteriovenous accesses by optodilutional and ultrasound dilution methods
CA2509332A1 (en) Extravasation detector
JP2009297404A (en) Device for preventing needle detachment
CN209153750U (en) A kind of internal arteriovenous fistula functional analysis instrument inspection utensil
MacDonald et al. Identifying a new reality: zero vascular access recirculation using ultrasound dilution
Harrington Use errors with health care technologies: an inconvenient truth
Salimi et al. Predicting hemodialysis access failure with the measurement of dialysis access recirculation
Frinak et al. Detection of Hemodialysis Venous Needle Dislodgment Using Venous Access Pressure Measurements: A Simulation Study